Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × samarium Sm-153 lexidronam × Clear all

NCT00602706 2011-05-16

Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Phase 1/2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00478075 2011-05-11

Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell